Haemonetics names CFO James D'Arecca as principal accounting officer following controller's departure
HAEMONETICS CORP
James C. D'Arecca, EVP/CFO, assumes principal accounting officer role effective Aug 5, 2022, replacing departing controller Dan Goldstein.
2022 annual meeting held Aug 5 with 94.1% quorum; all nine director nominees elected with majority support.
Shareholders approved say-on-pay (43.98M for, 2.71M against) and ratified Ernst & Young as auditor (47.09M for, 1.16M against).
Vote totals show high approval for most directors; Charles Dockendorff and Ellen Zane received the most withhold votes at 5.96M and 3.27M, respectively.
On August 5, 2022, the Board of Directors of Haemonetics Corporation (the “Company”) appointed James C. D’Arecca, Executive Vice President, Chief Financial Officer, as the Company’s principal accounting officer
Key facts
Extracted from this filing and checked against the source text.
Executive changeSEC 8-K Item 5.02confidence 0.95
James C. D'Arecca was appointed as principal accounting officer at HAEMONETICS CORP.
Action
appointed
Role
principal accounting officer
Exact text from the filing
On August 5, 2022, the Board of Directors of Haemonetics Corporation (the “Company”) appointed James C. D’Arecca, Executive Vice President, Chief Financial Officer, as the Company’s principal accounting officer
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.